Literature DB >> 24274861

Obesity and liver disease: the epidemic of the twenty-first century.

Kathleen E Corey1, Lee M Kaplan.   

Abstract

Obesity is a rapidly growing health problem that is associated with more than 65 comorbidities and results in substantially increased all-cause mortality. The increase of obesity has played an important role in the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the most common cause of liver disease in the United States. Understanding the prevalence, comorbidities, and pathogenesis of obesity provides an essential foundation for clinicians who care for individuals with NAFLD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Energy balance; Fat mass; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obesity; Weight loss

Mesh:

Year:  2014        PMID: 24274861     DOI: 10.1016/j.cld.2013.09.019

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  38 in total

1.  Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists.

Authors:  Rena K Fox
Journal:  Dig Dis Sci       Date:  2015-05-19       Impact factor: 3.199

2.  Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Xiaobo Wang; Ze Zheng; Jorge Matias Caviglia; Kathleen E Corey; Tina M Herfel; Bishuang Cai; Ricard Masia; Raymond T Chung; Jay H Lefkowitch; Robert F Schwabe; Ira Tabas
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

Review 3.  Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

Authors:  Tyler J Severson; Siddesh Besur; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

4.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis.

Authors:  Adam Schmitz; Paul Haste; Matthew S Johnson
Journal:  J Gastrointest Surg       Date:  2019-09-04       Impact factor: 3.452

5.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

6.  The Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Mehrangiz Ebrahimi-Mameghani; Soodabeh Aliashrafi; Yousef Javadzadeh; Mohammad AsghariJafarabadi
Journal:  Health Promot Perspect       Date:  2014-07-12

Review 7.  Outcomes of abdominal surgery in patients with liver cirrhosis.

Authors:  Juan C Lopez-Delgado; Josep Ballus; Francisco Esteve; Nelson L Betancur-Zambrano; Vicente Corral-Velez; Rafael Mañez; Antoni J Betbese; Joan A Roncal; Casimiro Javierre
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

8.  Predictive Factors and Time to Development of Hepatic Decompensation in Patients with Non-alcoholic Fatty Liver Disease.

Authors:  Heidi S Ahmed; Natalie Pedersen; Manju Bengaluru Jayanna; Patrick Ten Eyck; Antonio Sanchez; Arvind R Murali
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

9.  Live cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices.

Authors:  Ricard Masia; William J McCarty; Carolina Lahmann; Jay Luther; Raymond T Chung; Martin L Yarmush; Gary Yellen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-10-12       Impact factor: 4.052

10.  Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Bishuang Cai; Paola Dongiovanni; Kathleen E Corey; Xiaobo Wang; Igor O Shmarakov; Ze Zheng; Canan Kasikara; Viralkumar Davra; Marica Meroni; Raymond T Chung; Carla V Rothlin; Robert F Schwabe; William S Blaner; Raymond B Birge; Luca Valenti; Ira Tabas
Journal:  Cell Metab       Date:  2019-12-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.